10 January 2020 - Deborah Wilkes
Archived
Norway is reverse-switching oral medicines containing diclofenac from non-prescription to prescription-only status with effect from 7 July 2020.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.